Unknown PHASE1 INTERVENTIONAL 2-arm NCT02614352

Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd

Interventions AG1502 Atorvastatin + Candesartan

Updated 5 times since 2017 Last updated: Nov 24, 2015 Primary completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02614352, this PHASE1 trial focuses on Healthy Male Subjects and remains ongoing. Sponsored by Ahn-Gook Pharmaceuticals Co.,Ltd, it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Feb 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ahn-Gook Pharmaceuticals Co.,Ltd

Data source: Ahn-Gook Pharmaceuticals Co.,Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.